Fosun Pharma

Update in progress

600196.SS (Shanghai)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Shanghai Fosun Pharmaceutical Group engages in pharmaceutical, medical devices, diagnostics, healthcare services, and hospital operations in China and internationally. It comprises five segments: Pharmaceuticals; Medical Devices and Medical Diagnosis; Medical Services; Medical Distribution and Retail; and Others. The company develops therapies in oncology, immune-inflammatory, metabolism, anti-infection, CNS, and cardiovascular areas, and provides APIs, mRNA vaccines, aesthetic devices, diagnostic solutions, online/offline medical services, and hospital operations. Founded 1994, based in Shanghai.

Company score

Sentiment: 0.39; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.22; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.01; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.07; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.23; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive